Nesfatin-1 was found to be able to improve insulin resistance and glucose uptake through Akt/Adenosine Monophosphate activated Protein Kinase (AMPK)/Target of Rapamycin Complex 2 (TORC2) pathway in an animal study (20). This evidence concerns the gene NUCB2 and Insulin resistance.